Published in Cancer Weekly, June 1st, 2010
"We are honored and proud to accept the 'Emerging Company of the Year' award and I want to congratulate everyone at Neogenix who made this possible. We are looking forward to growing successfully in the future," said Dr. Philip Arlen, CEO of Neogenix Oncology. About Neogenix Oncology Neogenix Oncology is a development stage biotechnology company focused on developing and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.